• 1
    Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 714
  • 2
    Terris MK, McNeal JE, Stamey TA. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J Urol 1992; 148: 82932
  • 3
    Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995; 45: 212
  • 4
    Montie JE, Wood DP, Jr, Pontes JE, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 1989; 63: 3815
  • 5
    Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 1989; 141: 10914
  • 6
    Sakr WA, Grignon DJ, Crissman JD et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo 1994; 8: 43943
  • 7
    Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71: 9338
  • 8
    Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 36874
  • 9
    Weldon VE, Tavel FR, Neuwirth H, Cohen R. Failure of focal prostate cancer on biopsy to predict focal prostate cancer. the importance of prevalence. J Urol 1995; 154: 10747
  • 10
    Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992; 23: 2739
  • 11
    Hoedemaeker RF, Ruijter ETG, Ruizeveld de Winter JA, Van der Kaa CA, Van der Kwast TH. Processing radical prostatectomy specimens: a comprehensive and standardized protocol. J Urol Pathol 1998; 9: 21122
  • 12
    Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl 1992; 4: 12938
  • 13
    Hoedemaeker RF, Rietbergen JB, Kranse R, Van Der Kwast TH, Schroder FH. Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer. World J Urol 1997; 15: 33945
  • 14
    Ohori M, Wheeler TM, Dunn JK, Stamey TA, Scardino PT. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 1994; 152: 171420
  • 15
    Cupp MR, Bostwick DG, Myers RP, Oesterling JE. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol 1995; 153: 15438
  • 16
    Epstein JI, Walsh PC, Sauvageot J, Carter HB. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol 1997; 158: 188690
  • 17
    Hoedemaeker RF, Boeken Kruger AE, Van der Kwast TH. How many biopsies should be taken for proper diagnosis and grading? In KurthKH, MickischGW eds, Renal, Bladder and Prostate cancer: An Update. The Proceedings of the V Congress on Progress and Controversies in Oncological Urology (PACIOU V). Rotterdam: Parthenon Publishing Group, 1999: 10916
  • 18
    Irwin MB, Trapasso JG. Identification of insignificant prostate cancers: analysis of preoperative parameters. Urology 1994; 44: 8627
  • 19
    Goto Y, Ohori M, Arakawa A, Kattan MW, Wheeler TM, Scardino PT. Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 1996; 156: 105963
  • 20
    Vis AN, Hoedemaeker RF, Van Der Kwast TH, Schroder FH. Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification model. Prostate 2001; 46: 15462